Sofinnova Partners Secures €1.2 Billion to Drive Innovation in Healthcare and Life Sciences March 4, 2025
Callio Therapeutics Launches with $187 Million to Pioneer Multi-Payload Antibody-Drug Conjugates for Cancer Treatment March 4, 2025
Revolutionizing Cancer Treatment: Callio Therapeutics Launches with $187 Million Series A Funding to Develop Next-Gen Multi-Payload Antibody-Drug Conjugates March 4, 2025
Revolutionizing Cancer Treatment: Callio Therapeutics Launches with $187 Million to Develop Advanced Multi-Payload Antibody-Drug Conjugates March 3, 2025
Callio Therapeutics: Revolutionizing Cancer Treatment with $187 Million Funding for Innovative Multi-Payload Antibody-Drug Conjugates March 3, 2025
Hope on the Horizon: Leqembi Moves Closer to Approval in Europe for Alzheimer’s Treatment March 3, 2025
European Regulators Move Closer to Approving Leqembi: A Breakthrough in Alzheimer’s Treatment March 3, 2025
Leqembi’s Path to European Approval: A Promising Advance in Alzheimer’s Treatment Amid Safety Considerations March 3, 2025
Leqembi’s Path to European Approval: A Milestone in Alzheimer’s Treatment Amid Safety Concerns March 2, 2025
